Description

INTACOXIA 90 MG

Indications

INTACOXIA 90 MG is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used for the treatment of acute pain episodes, including postoperative pain and pain related to dental procedures. The medication is designed to provide relief from moderate to severe pain, improving the quality of life for patients suffering from chronic pain conditions.

Mechanism of Action

INTACOXIA 90 MG contains the active ingredient etoricoxib, which belongs to a class of medications known as selective COX-2 inhibitors. The primary mechanism of action involves the selective inhibition of the cyclooxygenase-2 (COX-2) enzyme, which plays a crucial role in the inflammatory process. By inhibiting COX-2, INTACOXIA reduces the production of prostaglandins, which are compounds that mediate inflammation and pain. This selective inhibition helps to minimize gastrointestinal side effects commonly associated with non-selective nonsteroidal anti-inflammatory drugs (NSAIDs).

Pharmacological Properties

INTACOXIA is characterized by its pharmacokinetic properties, which include rapid absorption and a high bioavailability of approximately 100%. Peak plasma concentrations are typically reached within 1 to 3 hours after oral administration. The drug is extensively metabolized in the liver, primarily via cytochrome P450 2C9, and its elimination half-life is approximately 22 hours, allowing for once-daily dosing. The elimination of etoricoxib occurs mainly through the urine, with a small percentage excreted in feces.

Contraindications

INTACOXIA 90 MG is contraindicated in patients with a known hypersensitivity to etoricoxib or any of its components. It should not be used in individuals with a history of severe allergic reactions, such as anaphylaxis, to NSAIDs. Additionally, the medication is contraindicated in patients with active peptic ulcer disease, gastrointestinal bleeding, or inflammatory bowel disease. Patients with severe liver or renal impairment should also avoid using INTACOXIA due to the potential for increased toxicity.

Side Effects

Like all medications, INTACOXIA 90 MG may cause side effects. Common adverse reactions include headache, dizziness, and gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Serious side effects may include cardiovascular events, such as myocardial infarction and stroke, particularly in patients with pre-existing cardiovascular risk factors. Renal impairment and liver function abnormalities have also been reported. Patients should be monitored for any signs of adverse reactions, and the medication should be discontinued if severe side effects occur.

Dosage and Administration

The recommended dosage of INTACOXIA 90 MG varies depending on the condition being treated. For osteoarthritis and rheumatoid arthritis, the usual dose is 90 mg once daily. For acute pain, a single dose of 90 mg may be administered, with the option to repeat after 24 hours if necessary. It is important to use the lowest effective dose for the shortest duration possible to minimize the risk of adverse effects. Patients should take the medication orally, with or without food, and should not exceed the prescribed dosage.

Interactions

INTACOXIA may interact with several other medications, which can alter its efficacy or increase the risk of adverse effects. Co-administration with anticoagulants, such as warfarin, may enhance the risk of bleeding. Additionally, the use of etoricoxib with other NSAIDs or corticosteroids is not recommended due to the potential for increased gastrointestinal toxicity. Patients taking diuretics or antihypertensive medications should be monitored closely, as INTACOXIA may reduce the effectiveness of these drugs. It is essential for patients to inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Before initiating treatment with INTACOXIA 90 MG, healthcare providers should conduct a thorough assessment of the patient’s medical history, including any history of cardiovascular disease, gastrointestinal disorders, or liver and kidney function abnormalities. Caution is advised in elderly patients and those with a history of hypertension, as the medication may cause fluid retention and increase blood pressure. Regular monitoring of renal function and liver enzymes is recommended during treatment, especially in patients with pre-existing conditions. Patients should also be advised to report any unusual symptoms or side effects promptly.

Clinical Studies

Clinical studies have demonstrated the efficacy of INTACOXIA 90 MG in managing pain and inflammation associated with various conditions. In randomized controlled trials, etoricoxib has shown significant improvement in pain relief and functional outcomes in patients with osteoarthritis and rheumatoid arthritis compared to placebo and traditional NSAIDs. Additionally, studies have indicated that INTACOXIA has a favorable gastrointestinal safety profile compared to non-selective NSAIDs, making it a preferred option for patients at risk of gastrointestinal complications. Long-term studies have also evaluated the cardiovascular safety of etoricoxib, with mixed results, emphasizing the need for careful patient selection and monitoring.

Conclusion

INTACOXIA 90 MG is an effective medication for the management of pain and inflammation in various conditions, offering a selective approach to COX-2 inhibition. While it provides significant benefits in terms of pain relief and gastrointestinal safety, careful consideration of contraindications, potential side effects, and drug interactions is essential. Patients should be adequately informed about the proper use of INTACOXIA and monitored for any adverse reactions during treatment. As with any medication, the goal is to achieve optimal therapeutic outcomes while minimizing risks.